NICE Decision On Arthritis Opens Door For Biosimilars In England

UK Recommends Treating Moderate Rheumatoid Arthritis With Three Biologic Molecules

 
• By Dave Wallace
  
Pile of British money pounds sterling new one pound coins GBP in four piles close-up with NHS above. Rising cost of National Health Service concept UK
Certain biologics were found to be a cost-effective use of NHS resources for treating moderate rheumatoid arthritis
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United Kingdom

More from Europe